Trinbelimab (r-anti-D) is a recombinant anti-Rh(o)-D immunoglobulin. Trinbelimab can be used for the prevention of immune reactions caused by Rh (D) blood group incompatibility between mother and fetus, as well as for research on hemolytic disease of the fetus/newborn (HDFN)[1].
Molecular Weight:
(145.47 kDa)
Purity:
99
CAS Number:
[2415078-44-1]
Target:
Others
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted